KR20130041419A - Black ginseng chicken soup for improving lipid metabolism and its manufacturing method - Google Patents
Black ginseng chicken soup for improving lipid metabolism and its manufacturing method Download PDFInfo
- Publication number
- KR20130041419A KR20130041419A KR1020110105639A KR20110105639A KR20130041419A KR 20130041419 A KR20130041419 A KR 20130041419A KR 1020110105639 A KR1020110105639 A KR 1020110105639A KR 20110105639 A KR20110105639 A KR 20110105639A KR 20130041419 A KR20130041419 A KR 20130041419A
- Authority
- KR
- South Korea
- Prior art keywords
- black
- ginseng
- samgyetang
- garlic
- black ginseng
- Prior art date
Links
- 241000208340 Araliaceae Species 0.000 title claims abstract description 68
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 68
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 68
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 68
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 17
- 230000037356 lipid metabolism Effects 0.000 title claims abstract description 14
- 235000014347 soups Nutrition 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title abstract description 8
- 241000383638 Allium nigrum Species 0.000 claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 240000002234 Allium sativum Species 0.000 abstract description 21
- 235000004611 garlic Nutrition 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 11
- 238000009835 boiling Methods 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 22
- 235000020710 ginseng extract Nutrition 0.000 description 15
- 238000002835 absorbance Methods 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 235000012000 cholesterol Nutrition 0.000 description 9
- 235000005911 diet Nutrition 0.000 description 9
- 230000037213 diet Effects 0.000 description 9
- 230000032683 aging Effects 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 7
- 108010082126 Alanine transaminase Proteins 0.000 description 7
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 7
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 235000009200 high fat diet Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 108010023302 HDL Cholesterol Proteins 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- -1 DPPH radicals Chemical class 0.000 description 3
- 108010010234 HDL Lipoproteins Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000004153 glucose metabolism Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000057621 Glycerol kinases Human genes 0.000 description 2
- 108700016170 Glycerol kinases Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- 241001247821 Ziziphus Species 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000000923 atherogenic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- HORQAOAYAYGIBM-UHFFFAOYSA-N 2,4-dinitrophenylhydrazine Chemical compound NNC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O HORQAOAYAYGIBM-UHFFFAOYSA-N 0.000 description 1
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 1
- OZRGLPAXIYOWIG-HZPUXBNGSA-N 4-nitrobenzylamine Chemical compound CC(C)C(CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CCCC[C@]4(C)[C@H]3CC[C@]12C)=O OZRGLPAXIYOWIG-HZPUXBNGSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108010089254 Cholesterol oxidase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- WVVOBOZHTQJXPB-UHFFFAOYSA-N N-anilino-N-nitronitramide Chemical compound [N+](=O)([O-])N(NC1=CC=CC=C1)[N+](=O)[O-] WVVOBOZHTQJXPB-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000000019 Sterol Esterase Human genes 0.000 description 1
- 108010055297 Sterol Esterase Proteins 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000579 abdominal fat Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000002792 antioxidant assay Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000741 diarrhetic effect Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- OFJHGWPRBMPXCX-UHFFFAOYSA-M lithium;2-oxopropanoate Chemical compound [Li+].CC(=O)C([O-])=O OFJHGWPRBMPXCX-UHFFFAOYSA-M 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/50—Poultry products, e.g. poultry sausages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L23/00—Soups; Sauces; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/105—Natural spices, flavouring agents or condiments; Extracts thereof obtained from liliaceae, e.g. onions, garlic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/10—General methods of cooking foods, e.g. by roasting or frying
- A23L5/13—General methods of cooking foods, e.g. by roasting or frying using water or steam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
Abstract
Description
본 발명은 지질대사 개선용 흑삼계탕 및 그 제조방법에 관한 것이다.The present invention relates to a black samgyetang for improving lipid metabolism and a method of manufacturing the same.
삼계탕은 단백질 함량이 높으면서 상대적으로 칼로리, 지방, 콜레스테롤 함량이 낮은 닭고기를 주원료로 하고, 인삼, 찹쌀, 밤, 마늘, 대추 등 건강 기능성 식물소재를 부재료로 첨가하여 제조되는 식품으로써 동물성 식품과 식물성 식품과의 조화를 이루는 보신용 전통 식품이다.Samgyetang is a food made from chicken with high protein content and low in calories, fat and cholesterol, and added healthy functional plant materials such as ginseng, glutinous rice, chestnut, garlic and jujube as subsidiary ingredients. It is a traditional food for the gods in harmony with.
이러한 삼계탕은 사상체질의학을 연구한 동무(東武) 이제마(李濟馬)가 저술한 동의수세보원(東醫壽世保元)(1894)에서 “삼계고(蔘鷄膏)”라는 용어를 사용하며 설명하였듯이 “소음인과 설사병 치료제로써 소음인에게는 적합한 음식이나, 몸에 열이 많은 소양인, 태양인들이 몸이 좋지 않은 상태에서 복용하면 현기증, 복통, 구토 등의 부작용이 나타날 수 있다”고 한다. 그러므로 이러한 부작용을 극복하기 위한 방법의 개발이 요구되고 있다.Samgyetang uses the term "samgyego" in Dongsui Susebowon (1894), written by Dongmu Jesuma, a researcher of Sasang Constitutional Medicine. As explained, "Noises and diarrheal medicines that are suitable for the noise person, Soyangin people with a lot of heat, the sun people take a bad condition when you take a side effect such as dizziness, abdominal pain, vomiting can be said. Therefore, the development of a method for overcoming these side effects is required.
본 발명은 상기한 태양인들에게 나타날 수 있는 부작용을 극복하면서 지질대사를 개선하기 위하여 흑삼과 흑마늘을 선택적으로 하나 이상 사용한 흑삼계탕 및 그 제조방법을 제공하는 데 있다.The present invention provides a black ginseng soup and a method of manufacturing the same using at least one of black ginseng and black garlic to improve lipid metabolism while overcoming the side effects that may occur in the above-mentioned sun people.
상기한 목적을 달성하기 위한 본 발명의 특징은, 닭 100중량 기준으로 흑삼 또는 흑마늘 중에서 하나 이상 선택하여 각각 1~10중량부 첨가하여 제조되는 지질대사 개선용 흑삼계탕 및 그 제조방법에 있다.A feature of the present invention for achieving the above object is a black samgyetang for improving lipid metabolism prepared by adding one to 10 parts by weight each of at least one selected from black ginseng or black garlic on a chicken 100 weight basis.
상기한 본 발명에 의하면 흑삼 또는 흑마늘을 삼계탕 제조시 수삼 대신 사용하여 흑삼계탕을 제조함으로서, 기호성이 우수한 삼계탕을 제공할 수 있게 되어 건강보양식으로서의 명품화를 유도할 수 있다.According to the present invention described above by using black ginseng or black garlic instead of ginseng in the preparation of samgyetang, it is possible to provide black gyetang with excellent palatability, thereby inducing luxury as a health supplement.
또한, 흑삼을 동결건조시켜 보충급여하면서 동물실험을 수행한 결과 지질 및 당질대사 개선효능이 우수함을 확인하였기 때문에 당질 및 지질 대사 개선효능을 기대할 수 있는 삼계탕을 제공할 수 있게 되는 것이다.In addition, as a result of performing animal experiments while freeze-drying and supplementing black ginseng, it was confirmed that the effect of improving lipid and glucose metabolism was excellent, and thus it was possible to provide Samgyetang, which can be expected to improve sugar and lipid metabolism.
도 1은 일반 삼계탕 및 흑삼 또는 흑마늘이 첨가된 삼계탕의 전체 사진
도 2는 일반 삼계탕 및 흑삼 또는 흑마늘이 첨가된 삼계탕의 국물 사진1 is a general photo of Samgyetang and Samgyetang added with black ginseng or black garlic
Figure 2 is a soup photo of the samgyetang and Samgyetang added with black ginseng or black garlic
이하 본 발명의 실시예를 첨부된 도면을 참조하여 살펴본다.
Hereinafter, an embodiment of the present invention will be described with reference to the accompanying drawings.
I. 실험방법I. Experimental Method
1. 흑삼 제조1. Black Ginseng Manufacturing
흑삼은 인삼을 세척 후 60℃~80℃에서 20일간 숙성시켜 제조하고, 흑마늘 역시 세척한 후 70~80℃에서 20일간 숙성시켜서 만든다.Black ginseng is prepared by aging ginseng at 60 ° C. to 80 ° C. for 20 days. After washing black garlic, it is made by aging at 70 to 80 ° C. for 20 days.
이러한 흑삼 및 흑마늘을 제조하기 위한 숙성장치를 살펴보면, 자연 순환적인 공기 흐름을 통해 흑삼 숙성의 최적 조건이 균일하고 안정되게 유지 가능하도록 하는 것으로, 가열수단이 구비된 숙성로 내부에서 인삼이 인삼 교반부에 의하여 그 위치가 선회되고, 상기 숙성로 하부에는 공기를 토출하는 1개 이상의 토출관을 형성하고 상단에는 공기를 흡입하는 흡입관을 설치하여 로내 공기를 숙성로내에서 순환시키거나 로외 공기를 숙성로 내부로 주입함으로서, 자연 순환적인 공기 흐름을 통해 숙성로 내부가 균일한 온도 및 습도가 유지되도록 하여, 숙성시간이 단축되면서 고품질의 흑삼을 제공할 수 있도록 하였다.
Looking at the ripening device for producing such black ginseng and black garlic, ginseng is a ginseng stirring portion inside the aging furnace equipped with a heating means to maintain the optimum conditions of ripening black ginseng through natural circulation air flow Its position is rotated, and at least one discharge pipe for discharging air is formed in the lower part of the aging furnace, and a suction pipe for suctioning air is installed at the upper end to circulate the air in the furnace in the aging furnace or to mature the air outside the furnace. By injecting the inside, the inside of the aging furnace through the natural circulating air flow to maintain a uniform temperature and humidity, it was possible to provide a high-quality black ginseng while reducing the aging time.
2. 삼계탕 제조2. Manufacture of Samgyetang
① 인삼 및 흑삼의 뇌두를 잘라내고 마늘 및 흑마늘과 대추를 씻어 놓는다.① Cut off the heads of ginseng and black ginseng, and wash garlic, black garlic and jujube.
② 찹쌀은 깨끗이 씻어 30분 이상 불린다.② Wash glutinous rice for 30 minutes or more.
③ 닭은 삼계탕용 작은 것으로 준비하여 아래쪽의 기름을 잘라내고 찬 물에 핏물을 씻어 물기를 닦는다.③ Prepare chicken for small chicken soup, cut off the oil at the bottom, and wash the water with cold water to wipe dry.
④ 닭의 뱃속에 불린 찹쌀을 넣고 오므린다.④ Put the glutinous rice called in the belly of the chicken.
⑤ 냄비에 ④의 닭과 나머지 재료를 넣은 뒤 물 1 L를 부어 2시간 끓인다.⑤ chicken ④ and the remaining ingredients in the pot pour 1 L of water and boil for 2 hours.
상기에서 흑삼은 4년근 수삼을 항온항습의 조건에서 20일간 숙성시킨 것이고, 흑마늘은 생마늘을 적정 조건에서 숙성시켜 생마늘 특유의 냄새를 제거하고 신맛, 단맛이 어우러지도록 한 것으로 항산화, 항암 등의 효능이 과학적으로 널리 입증되고 있다.
In the above, black ginseng is matured for 4 days, ginseng roots for 20 days under the condition of constant temperature and humidity, and black garlic is ripened under appropriate conditions to remove the smell of raw garlic, so that the acidity and sweetness are combined. Scientifically proven.
3. (흑)삼계탕 재료 3. (Black) Samgyetang Ingredients
4. (흑)삼계탕의 기호도에 대한 관능검사 4. Sensory test on the taste of Samgyetang
① 삼계탕의 국물과 닭고기의 관능검사는 식품영양학을 전공하는 대학원생 10명을 패널로 선정하여 실험목적, 평가의 방법 및 특성 등을 숙지시킨 후 설문지를 사용하여 실시하였다. ① The sensory test of broth and chicken in Samgyetang was carried out using a questionnaire after 10 graduate students who majored in food and nutrition were selected by panel.
② 삼계탕 국물은 끓인 후 20분 안에 흰색의 일회용 종이컵에 5 mL씩 제공하였다. ② Samgyetang soup was boiled 5 mL each in a white disposable paper cup within 20 minutes.
③ 닭고기는 가슴살 부분만을 잘라 그릇에 담아 평가하였다. ③ chicken cut only the breast portion and put it in a bowl for evaluation.
④ 평가항목은 색(color), 향(flavor), 맛(taste) 및 전체적인 기호도(overall acceptability) 4 항목으로 7점척도법을 사용하여 아주싫다(1점), 싫다(2점), 조금 싫다(3점), 보통이다(4점), 조금좋다(5점), 좋다(6점), 아주좋다(7점)로 각각 평가하였다.
④ The evaluation items are color, flavor, taste, and overall acceptability. 4 items are disliked (1 point), disliked (2 points), slightly disliked using 7-point scale method ( 3 points), moderate (4 points), slightly good (5 points), good (6 points), and very good (7 points).
5. (흑)삼계탕의 건강 기능성 검정5. (Black) Samgyetang's health functional test
(1) 삼계탕 국물의 (1) Samgyetang soup inin vitrovitro 항산화 활성 검정 Antioxidant activity assay
① 전자공여능 측정 ; 각 시료의 전자공여능(EDA, Electron Donating bility)은 Kato등(1988)의 방법을 약간 수정하여 측정하였다. 즉, 시료 100 uL에 0.5 mM DPPH 용액을 250 uL 넣고 30분 동안 반응시킨 다음, 잔존하는 DPPH 라디칼을 517nm 에서의 흡광도를 UV/VIS Spectrophotometer로 측정하여 계산한다. ① measurement of electron donating ability ; Electron Donating bility (EDA) of each sample was measured by slightly modifying the method of Kato et al. (1988). That is, 250 μL of 0.5 mM DPPH solution was added to 100 uL of the sample and reacted for 30 minutes, and then the absorbed DPPH radicals at 517 nm were measured by UV / VIS Spectrophotometer.
EDA(%)={1-(시료첨가구의 흡광도/무첨가구의 흡광도)×100}EDA (%) = {1- (absorbance of sample addition / absorbance of no addition) x 100}
② 환원력 측정 ; 환원력은 Oyaizu(1986)의 방법에 준하여 시료 0.5 mL에 0.2 M phospate buffer (pH 6.6) 0.5 mL과 1% potassium ferricyanide 용액 0.5 mL를 가한 후 50℃에서 30분간 반응시킨다. 10% TCA 용액 0.5 mL을 첨가하고, 5000rpm에서 10분간 원심분리시킨다. 원심 분리한 상징액 0.5 mL에 증류수 0.5 mL과 0.1% FeCl3용액 0.1 mL을 가한 후 700 nm에서 흡광도를 측정한다.
② reducing force measurement; Reducing power was added to 0.5 mL of 0.2 M phospate buffer (pH 6.6) and 0.5 mL of 1% potassium ferricyanide solution in 0.5 mL of the sample according to the method of Oyaizu (1986). 0.5 mL of 10% TCA solution is added and centrifuged for 10 min at 5000 rpm. 0.5 mL of distilled water and 0.1 mL of 0.1% FeCl 3 solution were added to 0.5 mL of the centrifuged supernatant, and the absorbance was measured at 700 nm.
(2) (2) 흑삼계탕Black Samgyetang 제조용 재료인 흑삼의 Of black ginseng which is a material for manufacturing inin vivovivo 지질대사 개선 효능 검정 Lipid metabolism improvement efficacy test
① 동물실험 ; 고 지방식이를 섭취하면 비만 및 당뇨가 유도되는 동물(C57BL/6J 마우스 웅성 5주령)을 2주간 pellet 형의 Lab-chow식이로 적응시킨 후, 정상식이군(AIN-76 diet)과 고지방식이군(high fat 군(비만/당뇨 유도를 위한 고지방식이(fat; 20%) 및 고지방식이 군에 흑삼 보충급여 식이군을 편성하여, 6주간 사육시키면서, 당질 및 지질대사관련 생화학적 마커를 각각 측정한다. ① animal experiment; After ingesting a high fat diet, obese and diabetic animals ( 5 weeks old, C57BL / 6J mice) were adapted to pellet-type lab-chow diet for 2 weeks, followed by normal diet (AIN-76 diet) and high fat diet ( In the high fat group (fat; 20% fat and fat diet group for induction of obesity and diabetes), the black ginseng supplementary diet group was organized and raised for 6 weeks to measure biochemical markers related to glucose and lipid metabolism, respectively. do.
② 채혈 및 조직의 채취 ; 실험식이 급여가 7주가 되었을 때 동물을 18시간 절식 시킨 후, 1 %농도 케타민을 체중100g 당 0.2㎖ 량으로 복강 내에 주사하여 마취시킨 다음 개복하였다. 헤파린(1000unit/㎖)처리가 된 주사기로 하대정맥에서 혈액을 채취하여 1000g에서 15분간 원심 분리하여 혈장을 분리한 다음 분석 시까지 냉동 보관하였다. 혈액을 채취한 다음 즉시 조직(간, 신장, 심장, 부고환지방)을 적출하여, PBS로 여러 번 헹군 후 가제로 수분을 제거하여 칭량한다. ② blood collection and tissue collection; When the experimental diet reached 7 weeks, the animals were fasted for 18 hours, and then anesthetized by injecting 1% concentration of ketamine in 0.2 ml per 100 g of body weight, followed by anesthesia. Blood was collected from the inferior vena cava with a syringe treated with heparin (1000 units / mL), centrifuged at 1000 g for 15 minutes to separate plasma, and then stored frozen until analysis. After the blood is collected, the tissues (liver, kidney, heart, epididymal fat) are immediately removed, rinsed several times with PBS and weighed by gauze removal.
③ 간 조직은 효소활성도 측정 및 조직 지질 정량을 위해 분리 수집하여 액체질소에 급냉시킨 후 시료분석 시까지 -70 ℃에 보관한다. ③ Liver tissue is collected separately for quantification of enzyme activity and quantification of tissue lipid, quenched in liquid nitrogen and stored at -70 ℃ until sample analysis.
④ 생화학적 분석④ Biochemical Analysis
i. 혈중 중성지방 농도 측정 ; 혈중 중성지방은 Bucolo 방법에 준한 효소법을 적용한 Kit(아산제약)을 사용하여 측정한다. 중성지방에 lipoprotein lipase를 작용시켜 glycerol과 지방산으로 분해시킨 후 glycerol kinase(GK)를 첨가하여 생성된 L-glycerol phosphate oxidase, amino-antipyrin과 peroxidase와 반응시킨다. 이때 생성되는 quinone형의 색소를 550nm에서 흡광를 측정하여 glycerol 표준곡선과 비교하여 정량한다. i. Blood triglyceride concentration measurement; Blood triglycerides are measured using a kit (Asan Pharmaceuticals) applied with the enzyme method according to the Bucolo method. Lipoprotein lipase is applied to triglyceride to decompose it into glycerol and fatty acid and then react with L-glycerol phosphate oxidase, amino-antipyrin and peroxidase produced by adding glycerol kinase (GK). In this case, the resulting quinone pigment was measured at 550 nm for absorption and compared with the glycerol standard curve.
ii . 혈중 콜레스테롤 함량 측정 ; 혈장 총 콜레스테롤 정량은 Allain 등의 효소법을 응용한 측정용 시액 (아산제약 kit)을 사용하였다. 혈장 10uL에 효소시액 1.5 mL을 가하여 37℃에서 5분간 반응시킨다. 혈장 콜레스테롤은 cholesteryl ester(CE) 및 유리콜레스테롤 두 형태로 존재하므로, 이 모두를 정량하기 위해 CE를 cholesterol esterase에 의해 지방산과 유리 콜레스테롤로 전환시킨다. 유리 콜레스테롤은 cholesterol oxidase에 의해 H2O2와 Δ4-cholestenon으로 전환시키고, 이중 H2O2를 peroxidase 및 phenol, 4-amino-antiptrine과 혼합하여 적색으로 발색시킨 후, 500 nm에서 흡광도를 측정한다. 이때 콜레스테롤 표준용액(300 mg/dL)과 비교하여 정량한다. ii . Determination of blood cholesterol content; Plasma total cholesterol was measured using a test solution (Asan Pharmaceutical kit) applying the enzyme method such as Allain. 1.5 mL of enzyme solution is added to 10 uL of plasma and allowed to react at 37 ° C for 5 minutes. Plasma cholesterol exists in two forms, cholesteryl ester (CE) and free cholesterol, so to quantify both, CE is converted to fatty acids and free cholesterol by cholesterol esterase. Free cholesterol is converted into H 2 O 2 and Δ 4 -cholestenon by cholesterol oxidase, of which H 2 O 2 is mixed with peroxidase, phenol and 4-amino-antiptrine to develop red color, and then absorbance is measured at 500 nm. do. At this time, quantify by comparing with cholesterol standard solution (300 mg / dL).
iii . 혈중 HDL 콜레스테롤 함량 측정 ; 효소법에 의한 kit(아산제약)을 사용하여 측정한다. iii . Determination of blood HDL cholesterol content; Measured using kit (Asan Pharmaceuticals) by enzyme method.
Dextran-sulfate-Mg(II)을 혈장과 반응시켜 혈장 내 HDL fraction을 제외한 LDL, VLDL을 침전시킨 후 상층액을 검체로 사용하여 혈중의 총 콜레스테롤과 같은 방법으로 500nm에서 흡광도를 측정하고 콜레스테롤 표준곡선과 비교하여 정량한다.Dextran-sulfate-Mg (II) was reacted with plasma to precipitate LDL and VLDL except for the HDL fraction in the plasma.The supernatant was used as a sample to measure the absorbance at 500 nm using the same method as the total cholesterol in the blood. Quantify by comparison with
iv . HDL -C/ Total -C(%) = (HDL-C/Total-C)×100 iv . HDL -C / Total -C (%) = (HDL-C / Total-C) × 100
v. 동맥경화지수( Atherogenic index .A.I) = [(Total-C) - (HDL-C)] / HDL-C v. Atherogenic index (Atherogenic index .AI) = [(Total-C)-(HDL-C)] / HDL-C
vi . 혈장 GOT , GPT 활성도 측정을 통한 간조직 독성 분석 ; 혈장을 분리하여 간세포 손상과 밀접한 관련이 있는 glutamic oxaloacetic transaminase (GOT) 및 glutamic pyruvic transaminase (GPT) 활성도를 Reitman-Frankel)의 비색 분석법에 준한 효소법을 응용하여 분광광도계로 분석한다. 혈청 GOT는, L-aspartate와 α-ketoglutarate를 GPT는, D,L-alanine과 α-ketoglutarate를 첨가함에 의해서 혈장효소에 의해 기질이 pyruvate로 전환되며, 이 pyruvate를 2,4-dinitrophenylhydrazine과 반응시켜 0.4N NaOH를 가하면 비색으로 발색반응이 나타나고 이를 490~530 nm에서 흡광도를 측정하여 피루빈산 리튬의 표준곡선과 비교하여 활성도를 측정한다. vi . Hepatic toxicity analysis by measuring plasma GOT and GPT activity ; Plasma is isolated and analyzed for glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) activities, which are closely related to hepatocellular damage, by spectrophotometric analysis using enzyme method based on the colorimetric method of Reitman-Frankel. Serum GOT converts L-aspartate and α-ketoglutarate to GPT and D, L-alanine and α-ketoglutarate to convert the substrate to pyruvate by plasma enzymes, and reacts pyruvate with 2,4-dinitrophenylhydrazine. When 0.4N NaOH is added, colorimetric reaction occurs. The absorbance is measured at 490 ~ 530 nm and the activity is measured by comparing with the standard curve of lithium pyruvate.
GOT, GPT용 기질액을 1mL씩 취하고 37℃에서 5분간 방치한 다음, 혈장 0.2 mL를 가하여 37℃에서 GOT는 60분, GPT는 30분간 방치한다. Dinitrophenyl hydrazine 발색용 액을 1 mL씩 가하여 실온에 20분 방치하고 0.4N NaOH 용액 10 mL와 혼합하여 10분간 방치한 다음 흡광도를 측정한다. 이때 표준곡선은 혈청 transaminase 측정용 시약(Asan kit, Asan Co. Seoul, Korea) 중 검량선용 시약을 사용한다.
Take 1 mL each of GOT and GPT substrate solution, and leave it at 37 ° C for 5 minutes. Add 0.2 mL of plasma and leave GOT 60 minutes and GPT 30 minutes at 37 ° C. Add 1 mL of Dinitrophenyl hydrazine solution, and leave at room temperature for 20 minutes, mix with 10 mL of 0.4N NaOH solution, and leave for 10 minutes. Measure the absorbance. At this time, the standard curve is a calibration curve reagent in serum transaminase measurement reagent (Asan kit, Asan Co. Seoul, Korea).
IIII . 결과. result
1. 삼계탕의 외관1. Exterior of Samgyetang
삼계탕의 외관은 도 1에 나타내는 바와 같이 흑삼 또는 흑마늘이 첨가된 시료가 그렇지 않은 시료에 비하여 짙은 색을 띈다.
As shown in Fig. 1, the samgyetang has a darker color than the sample to which black ginseng or black garlic is added.
2. 국물의 색상2. Color of broth
삼계탕 국물의 색상 역시 흑삼 또는 흑마늘이 첨가된 시료가 그렇지 않은 시료에 비하여 짙은 색을 띈다.
Samgyetang broth also had a darker color than black ginseng or black garlic added samples.
3. 삼계탕의 기호도3. Symbol of Samgyetang
재료를 달리하여 끓인 삼계탕의 국물과 그 닭고기에 대한 기호도 검사는 다음과 같다. Samgyetang's broth boiled in different ingredients and the chicken's taste test are as follows.
영계에 수삼과 마늘을 넣은 일반적인 삼계탕과 흑삼+마늘 혹은 수삼+흑마늘을 넣고 끓인 삼계탕의 국물의 기호도 검사 결과는 표 2에 나타내었다.Table 3 shows the test results of broth of Samgyetang, which contains ginseng and garlic, and boiled Samgyetang with black ginseng + garlic or ginseng + black garlic.
국물의 색상에 대한 기호도는 수삼과 마늘을 넣은 삼계탕이 4.5, 흑삼과 마늘을 넣은 삼계탕도 4.4로 기호도가 좋았으나 수삼에 흑마늘을 넣은 삼계탕은 3.8로 낮았다. 흑마늘로 인해 국물의 색이 진하게 변한 것을 덜 선호하는 것으로 보인다. 향과 맛은 4.5~4.7로 시료 간 별 차이가 없는 것으로 나타났다. 국물의 질감은 흑삼과 마늘을 넣은 삼계탕이 4.8로 가장 높았고, 수삼과 흑마늘을 넣은 삼계탕이 4.5로 그 뒤를 따른다. 그러나 수삼과 마늘을 넣은 삼계탕은 4.0으로 나머지 두 시료에 비해 떨어지는 것으로 나타났다. 이는 숙성에 의해 생성된 흑삼과 흑마늘의 과당이 국물에 전해져 좋은 기호도를 보인 것으로 사료된다. 전체적인 기호도는 수삼과 마늘을 넣은 삼계탕이 4.1, 수삼과 흑마늘을 넣은 삼계탕이 4.0인데 반해 흑삼과 마늘을 넣은 삼계탕은 4.9로 가장 우수하였다. The color taste of the soup was 4.5 for Samgyetang with fresh ginseng and garlic, and 4.4 for Samgyetang with black ginseng and garlic, but 3.8 for Samgyetang with black garlic. The black garlic seems to prefer less the color of the broth. The aroma and taste ranged from 4.5 to 4.7, indicating no difference between the samples. The texture of broth was the highest at Samgyetang with black ginseng and garlic at 4.8, followed by 4.5 at Samgyetang with fresh ginseng and black garlic. However, Samgyetang with fresh ginseng and garlic was 4.0, which is lower than the other two samples. It is believed that fructose of black ginseng and black garlic produced by aging was transferred to broth and showed good palatability. The overall acceptability was the highest in Samgyetang with fresh ginseng and garlic, and 4.0 with Samgyetang with fresh ginseng and black garlic, while Samgyetang with black ginseng and garlic was 4.9.
수삼과 마늘을 넣은 일반적인 삼계탕과 흑삼+마늘 혹은 수삼+흑마늘을 넣고 끓인 삼계탕의 닭고기(가슴살)에 대한 기호도(표 3)로써, 색은 흑삼+마늘을 넣은 삼계탕 가슴살이 4.9로 가장 좋지만 수삼+마늘을 넣은 삼계탕 가슴살도 4.8로 좋다. 수삼+흑마늘, 흑삼+흑마늘 삼계탕의 가슴살은 4.4로 같다. 향과 맛은 흑삼+마늘을 넣은 삼계탕 가슴살이 5.2로 월등히 좋고 흑마늘+흑마늘 삼계탕의 가슴살은 4.1로 기호도가 낮게 평가되었다. 가슴살의 질감은 수삼+흑마늘을 넣은 삼계탕이 4.7로 가장 높았다. 전체적인 기호도는 흑삼+마늘을 넣은 삼계탕의 가슴살이 5.0으로 가장 높았고 흑마늘+흑마늘을 넣은 삼계탕의 가슴살은 3.8로 가장 낮은 기호도를 보였다.It is the symbol of the chicken (breast meat) of general samgyetang with black ginseng and garlic and boiled samgyetang with black ginseng + garlic or boiled ginseng + black garlic. Samgyetang breast meat is also good as 4.8. Fresh ginseng + black garlic, black ginseng + black garlic samgyetang breast is equal to 4.4. The flavor and taste of Samgyetang with black ginseng + garlic were 5.2, and the taste of black garlic + black garlic Samgyetang was 4.1. The texture of breast meat was the highest at Samgyetang with fresh ginseng + black garlic. The overall acceptability was the highest in Samgyetang with black ginseng + garlic, the highest in 5.0, and the lowest in Samgyetang with black garlic + black garlic, 3.8.
결국, 삼계탕을 끓일 때 어떤 부재료를 넣느냐에 따라 국물과 닭고기의 기호도에 영향을 미친다고 볼 수 있겠다. After all, what ingredients are added when boiling samgyetang can affect the taste of broth and chicken.
4. 삼계탕 국물의 건강 기능성(4. Health Functionality of Samgyetang Broth inin vitrovitro 항산화 활성)Antioxidant activity)
(1) 삼계탕 국물의 전자공여능 ; DPPH는 비교적 안정한 free radical로써 수소 공여체의 수소기와 결합하면 환원되어 DPPH의 보랏빛이 탈색되므로 항산화물질의 항산화활성 측정에 많이 이용되는 방법이다. 재료를 달리하여 끓인 삼계탕의 국물을 이용하여 전자공여능을 측정한 결과(표 4), 모든 시료에서 90 % 이상의 높은 전자공여능을 나타내었다. (1) electron donating ability of samgyetang soup ; DPPH is a relatively stable free radical, which is reduced when combined with hydrogen group of hydrogen donor, so that the purple color of DPPH is discolored. As a result of measuring the electron donating ability using the broth of boiled Samgyetang with different materials (Table 4), all samples showed high electron donating ability of more than 90%.
(2) 삼계탕 국물의 환원력 ; 항산화 활성의 여러 가지 기작 중에서 활성 산소종 및 유리기에 전자를 공여하는 능력을 환원력이라고 하며, 어떤 물질의 환원력은 항산화 활성에 대한 중요한 인자로 작용한다. 환원력에서의 흡광도 수치는 그 자체가 시료의 환원력을 나타나며, 높은 환원력을 가지는 물질은 흡광도의 수치가 높게 나타난다. 재료를 달리하여 끓인 삼계탕 국물의 환원력을 표 5에 제시하였다. (2) reducing power of samgyetang soup; Among various mechanisms of antioxidant activity, the ability to donate electrons to reactive oxygen species and free radicals is called reducing power, and the reducing power of certain substances acts as an important factor for antioxidant activity. The absorbance value at the reducing power itself represents the reducing power of the sample, and the material having high reducing power has a high absorbance value. The reducing power of the broiled Samgyetang soup with different ingredients is shown in Table 5.
수삼+마늘을 넣은 삼계탕, 흑삼+마늘을 넣은 삼계탕, 수삼+흑마늘을 넣은 삼계탕은 각각 0.046, 0.053, 0.079로 환원력이 매우 낮다. 흑마늘+흑마늘을 넣은 삼계탕은 0.375로 높은 흡광도 값을 가지는데 다른 시료들에 비해 환원력이 약 4.7~8.2배 높다. 마늘에 비해 높은 총 페놀과 플라보이드 함량을 가지는 흑마늘의 특성상 환원력이 높았을 것으로 사료된다. Samgyetang with fresh ginseng + garlic, samgyetang with black ginseng + garlic, and samgyetang with fresh ginseng + black garlic are 0.046, 0.053, and 0.079, respectively. Samgyetang with black garlic + black garlic has a high absorbance value of 0.375, which is about 4.7 ~ 8.2 times higher than other samples. It was considered that the reducing power of black garlic, which has higher total phenol and flavoid content, was higher than that of garlic.
흑마늘을 사용하여 삼계탕을 제조하는 경우에 국물의 항산화 활성(전자공여능, 환원력)은 높아 건강 증진용으로는 우수하다고 사료되지만, 식미에 대한 기호도는 흑삼을 사용하여 제조한 삼계탕이 훨씬 우수하기 때문에, 흑삼을 사용하여 흑삼계탕을 제조하는 편이 “기호도도 우수한 건강 증진용 삼계탕” 이라는 의미에서 바람직하다고 판단된다.
Samgyetang is prepared using black garlic because it has high antioxidant activity (electron donating ability, reducing power), which is considered to be good for health promotion.However, the taste of food tastes better than Samgyetang prepared using black ginseng. It is judged that black ginseng tang is produced using black ginseng in the sense of "Samgye tang for good health promotion".
이에, 흑삼의 생리활성 효능을 검정하였다. 즉, 고 지질식이에 의해서 당뇨가 유도되는 마우스에 흑삼 추출물을 보충급여하면서 사육한 마우스의 지질 및 당질 대사 개선 효능을 검토하였다. Thus, the physiological activity of black ginseng was assayed. In other words, the effect of improving lipid and glucose metabolism of mice bred while supplementing black ginseng extract in mice induced with diabetes due to high lipid diet was examined.
하기에서 N은 일반식이, HF는 고지질식이, HF+G는 고지질식이에 수삼추출물투여군, HF+BG는 고지질식이에 흑삼추출물 식이군을 나타내며, 상기에서 흑삼추출물 및 수삼추출물은 흑삼 1 kg에 6-10배량의 물을 첨가하여 121℃에서 1시간 추출한 추출물(열수 추출물)을 동결건조시켜, 각각 사료에 5 % 배합하여 급여하였다.
In the following, N is a general diet, HF is a high-fat diet, HF + G is a high-fat diet, ginseng extract administration group, HF + BG is a high-fat diet black ginseng extract diet group, in the black ginseng extract and the fresh ginseng extract is black ginseng 1 Six to ten times the amount of water was added to the kg, and the extract (hot water extract) extracted at 121 ° C. for 1 hour was lyophilized, and was fed by mixing 5% with each feed.
5. 5. 흑삼계탕Black Samgyetang 제조용 재료인 흑삼의 Of black ginseng which is a material for manufacturing inin vivovivo 지질대사 개선 효능 Lipid metabolism improvement effect
흑삼 추출물을 보충급여하면서 사육한 동물의 체중 및 장기 중량 증가를 비교한 결과(표 6), 식이 섭취율에는 별반 차이가 없었음에도 불구하고 흑삼 추출물을 급여한 군의 체중 감소 효과가 두드러짐을 알 수 있고, 특히 복부지방 조직의 감소효과가 뚜렸함을 알 수 있다.As a result of comparing the weight and organ weight gain of the animals reared with supplemented black ginseng extract (Table 6), the weight loss effect of the group fed the black ginseng extract was prominent, although there was no difference in the dietary intake rate. In particular, the abdominal adipose tissue was reduced significantly.
또한 혈장의 lipid profile을 분석한 결과(표 7), 고 지질 식이에 의해서 유도되는 총 콜레스테롤 함량이 감소하는 효과가 있었으며, HDL-콜레스테롤 함량은 증가하고 있으며, 동맥경화지수는 감소하고 있는 등 지질대사 개선에 효과적임을 알 수 있었다. 이러한 효과는 수삼추출물에 비해서 흑삼추출물에서 더욱 효과적이었다. In addition, as a result of analyzing the lipid profile of plasma (Table 7), total cholesterol content induced by high lipid diet was decreased, HDL-cholesterol content was increased, and arteriosclerosis index was decreased. It was found to be effective for improvement. This effect was more effective in black ginseng extract than ginseng extract.
간독성 지표인 GOT, GPT 레벨(표 8) 또한 흑삼추출물 보충급여의 경우, 감소하고 있었으며, 수삼추출물에 비해서 흑삼추출물에서 더욱 효과적이었다. GOT and GPT levels (Table 8), which are indicators of hepatotoxicity, were also decreased in the supplementation of black ginseng extract and were more effective in the black ginseng extract than the fresh ginseng extract.
적혈구의 항산화 효소활성을 검정한 결과(표 9), 대표적인 항산화 효소인 카탈라아제, 글루타치온퍼옥시다아제 등의 활성이 흑삼 추출물 급여에 의해서 활성화되고 있었으며, 이러한 효과 또한 수삼추출물에 비해서 흑삼추출물에서 더욱 효과적이었다. As a result of assaying the antioxidant enzyme activity of erythrocytes (Table 9), the activities of catalase, glutathione peroxidase, etc., which are representative antioxidant enzymes, were activated by feeding black ginseng extract, and this effect was also more effective in black ginseng extract than ginseng extract.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110105639A KR20130041419A (en) | 2011-10-17 | 2011-10-17 | Black ginseng chicken soup for improving lipid metabolism and its manufacturing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110105639A KR20130041419A (en) | 2011-10-17 | 2011-10-17 | Black ginseng chicken soup for improving lipid metabolism and its manufacturing method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20130041419A true KR20130041419A (en) | 2013-04-25 |
Family
ID=48440563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110105639A KR20130041419A (en) | 2011-10-17 | 2011-10-17 | Black ginseng chicken soup for improving lipid metabolism and its manufacturing method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20130041419A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200007323A (en) * | 2018-07-12 | 2020-01-22 | 정미애 | Manufacturing method for samgyetang using black ginseng and samgyetang using black ginseng manufactured by the same |
-
2011
- 2011-10-17 KR KR1020110105639A patent/KR20130041419A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200007323A (en) * | 2018-07-12 | 2020-01-22 | 정미애 | Manufacturing method for samgyetang using black ginseng and samgyetang using black ginseng manufactured by the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | Fermented kimchi reduces body weight and improves metabolic parameters in overweight and obese patients | |
Esmaillzadeh et al. | Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia | |
de Liz et al. | Açaí (Euterpe oleracea Mart.) and juçara (Euterpe edulis Mart.) juices improved HDL-c levels and antioxidant defense of healthy adults in a 4-week randomized cross-over study | |
Sugawara et al. | The 1975 type Japanese diet improves lipid metabolic parameters in younger adults: a randomized controlled trial | |
Fărcaș et al. | Nutritional properties and volatile profile of brewer’s spent grain supplemented bread | |
Polesel et al. | Nutrients intake and the risk of hepatocellular carcinoma in Italy | |
KR100816511B1 (en) | Manufacturing method of vinegar by using black rice and vinegar manufactured thereby | |
Oboh et al. | Nutritional and toxicological evaluation of Saccharomyces cerevisae fermented cassava flour | |
Su et al. | Dietary alfalfa powder supplementation improves growth and development, body health, and meat quality of Tibetan sheep | |
US20210046003A1 (en) | Health drink composition for preventing liver damage caused by alcohol while providing excellent hangover relief | |
Babich et al. | In vivo study of the potential of the carbohydrate-mineral complex from pine nut shells as an ingredient of functional food products | |
Tang et al. | Optimization of oat seed steeping and germination temperatures to maximize nutrient content and antioxidant activity | |
Ouyang et al. | Effects of dietary mulberry leaf powder on growth performance, blood metabolites, meat quality, and antioxidant enzyme-related gene expression of fattening Hu lambs | |
Kang et al. | Anti-obesity and hypolipidemic effects of Lycium chinense leaf powder in obese rats | |
Li et al. | Uncovering the effect of Moringa oleifera Lam. leaf addition to Fuzhuan Brick Tea on sensory properties, volatile profiles and anti-obesity activity | |
KR101344916B1 (en) | rice doenjang and manufacturing method thereof | |
KR20130041419A (en) | Black ginseng chicken soup for improving lipid metabolism and its manufacturing method | |
KR100855665B1 (en) | Kochujang for anti-cholesterol comprising persimmon fruit and extracts of herb medicine mixture and a preparation method thereof | |
Chen et al. | Effects of Taiwanese yam (Dioscorea alata L. cv. Tainung No. 2) on the mucosal hydrolase activities and lipid metabolism in Balb/c mice | |
KR20160009001A (en) | Meju and doenjang and manufactruing thereof | |
KR20130104703A (en) | Gochujang and manufactruing thereof | |
CN113549583A (en) | Complex microbial inoculant, application of complex microbial inoculant and method for preparing quinoa fermented milk by using complex microbial inoculant | |
CN108420813B (en) | Application of the alkyl gallates as glyoxal and methyl-glyoxal inhibitor | |
Pathirana et al. | Evaluation of nutritional composition of defatted coconut flour incorporated biscuits | |
KR100872051B1 (en) | Watery plain kimchi with chitosan-ascorbate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |